| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |